Algunas Inc. dba Woodland Hills Compounding Pharmacy
Form 483 issued October 11, 2018 · Woodland Hills, California
- Inspection
- Oct 4, 2018
- Investigator
- Rumany C. Penn
- Observations
- 1
- Pages
- 2
- FEI number
- 3011830726
In short: On October 11, 2018, FDA issued a Form 483 with 1 observation to Algunas Inc. dba Woodland Hills Compounding Pharmacy in Woodland Hills, California (FEI 3011830726) after an inspection that ran Oct 4, 2018. The investigator was Rumany C. Penn.
What FDA observed
Preview: the opening words of each observation- 01FDCA 501(a)(2)(A)
You used a non-pharmaceutical grade component in the formulation…
This inspection in context
Rumany C. Penn
21 documents · 2016–2022
Cites 211.42 (design and construction features) more than any other section. Most of their documents are for sites in California.
The firmAlgunas Inc. dba Woodland Hills Compounding Pharmacy history
All 3 documents on file for this site, in date order, with what was cited at each inspection.
Similar 483sMore form 483s
Browse other documents of this type.
Questions about this 483
What did FDA find at Algunas Inc. dba Woodland Hills Compounding Pharmacy?
FDA listed 1 observation on this Form 483. The opening words of each observation are shown on this page.
Who inspected Algunas Inc. dba Woodland Hills Compounding Pharmacy?
Rumany C. Penn is named on this Form 483, for the inspection of Oct 4, 2018. Each investigator has a profile showing what they cite most.
When was Algunas Inc. dba Woodland Hills Compounding Pharmacy inspected by FDA?
The inspection ran Oct 4, 2018, and the Form 483 is dated October 11, 2018.
How do I get the full Form 483 for Algunas Inc. dba Woodland Hills Compounding Pharmacy?
Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.